z-logo
Premium
Transoral laser microsurgery for oral squamous cell carcinoma: Oncologic outcomes and prognostic factors
Author(s) -
Sinha Parul,
Hackman Trevor,
Nussenbaum Brian,
Wu Ningying,
Lewis James S.,
Haughey Bruce H.
Publication year - 2014
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.23293
Subject(s) - medicine , transoral laser microsurgery , perineural invasion , stage (stratigraphy) , basal cell , neck dissection , microsurgery , surgery , oral cavity , oncology , surgical margin , cancer , head and neck cancer , dentistry , paleontology , biology
Background Modest survival rates are published for treatment of oral squamous cell carcinoma (OSCC) using conventional approaches. Few cohort studies are available for transoral resection of OSCC. Methods Analysis for recurrence, survival, and prognosis of patients with OSCC treated with transoral laser microsurgery (TLM) ± neck dissection was obtained from a prospective database. Results Ninety‐five patients (71 patients had stages T1–T2 and 24 had stages T3–T4 disease) with minimum follow‐up of 24 months met criteria and demonstrated negative margins in 95%. Five‐year local control (LC) and disease‐specific survival (DSS) were 78% and 76%, respectively. Surgical salvage achieved an absolute final locoregional control of 92%. Immune compromise and final margins were prognostic for LC, whereas T classification, N classification, TNM stage, comorbidity, and perineural invasion were also significant for DSS. Conclusion We document a large series of patients with OSCC treated with TLM, incorporating T1 to T4 primaries. A significant proportion of stage III/IV cases demonstrates feasibility of TLM in higher stages, with final margin positivity of 5%, LC greater than 90%, and comparable survival outcomes. © 2013 Wiley Periodicals, Inc. Head Neck 36 : 340–351, 2014

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here